Gastrokard Division
Drugkard Biotech is thrilled to introduce Gastrokard, our premier division dedicated to the art and science of digestion. Focused on delivering high-impact, rapid-relief formulations, Gastrokard is the new benchmark for excellence in gastrointestinal care. We are currently seeking dynamic, high-performing partners to join our Gastro Monopoly Franchise Network. This is your opportunity to deliver premium, life-changing healthcare solutions while building a rewarding venture in a high-demand market
PediaElite Division
Drugkard Biotech proudly advances its legacy of excellence with the launch of PediaElite — a premium division strategically focused on the rapidly expanding paediatric healthcare segment.
Engineered for superior child wellness, PediaElite presents a powerful portfolio of advanced syrups, precision-formulated drops, and scientifically developed nutritional supplements, addressing the evolving needs of modern paediatric care across India.
We invite visionary entrepreneurs to partner with us through our exclusive Paediatric Monopoly Franchise opportunity, offering unmatched monopoly rights, elite promotional support, and a strong commitment to clinical efficacy and product innovation.
Step into the future of paediatric healthcare with a brand that stands for trust, quality, and growth.
PediaElite — Elevating the Standard of Childhood Wellness.
Medvaxa Division
Drugkard Biotech is proud to present Medvaxa, our specialized powerhouse for general medicine innovation. We have synthesized decades of pharmaceutical expertise into a sleek, high-tier portfolio that addresses the core of human health. As we expand our footprint, we are seeking high-performing partners to lead our Medvaxa Franchise Network. This is more than a business opportunity; it is a mission to deliver elite, life-saving solutions to every corner of the nation. Exceptional range. Elite results. Endless potential.
Orthovaxa Division
Drugkard Biotech is pleased to introduce Orthovaxa, our dedicated division for orthopaedic advancement. Focused on delivering elite formulations for bone and joint health, Orthovaxa serves as a powerhouse for therapeutic innovation. We are currently seeking dynamic franchise partners to join us in this vital sector, offering a rewarding opportunity to provide premium orthopaedic solutions to those who need them most.
Gynovaxa Division
In an era where women’s wellness is a global priority, Drugkard Biotech is proud to announce the launch of its visionary —a dedicated powerhouse for gynaecological innovation.
In response to the increasing demand for premium women’s healthcare, Gynovaxa introduces an exclusive Gynae Monopoly Franchise Opportunity. This initiative empowers entrepreneurs to establish rewarding ventures within this vital medical sector.
The Gynovaxa division boasts an elite portfolio of over 10 breakthrough formulations, positioning Drugkard Biotech as a pioneer in gynaecological therapeutics. We are now inviting dynamic partners to capitalize on this premier market opportunity and join us in our mission to revolutionize women's healthcare.
WHO-GMP Certified Quality Assurance
Our WHO-GMP certification validates strict quality control at every production stage, delivering trusted medicines that meet international safety benchmarks.